臨床試験マッチングソフトウェアの世界市場規模、シェア、産業動向分析レポート：展開形態別、最終用途別、地域別展望と予測、2023年～2030年

臨床試験マッチングソフトウェア市場規模は2030年には3億6,270万米ドルに達すると予測され、予測期間中のCAGRは13.5%の市場成長率で上昇する見込みです。

さらに、COVID-19パンデミックは、市場を含むヘルスケア産業の様々な側面に大きな影響を与えました。COVID-19の大流行は、医薬品開発と公衆衛生における臨床試験の重要性を浮き彫りにしました。この意識の高まりと緊急性は、研究者や製薬会社がCOVID-19治療やワクチンに関連する臨床試験の迅速化を求めたため、臨床試験マッチング・ソフトウェアに対するより大きな需要を牽引しました。パンデミックは、ヘルスケアと臨床試験部門におけるより効率的なデータ共有と分析の必要性を強調しました。臨床試験マッチング・ソフトウェアは、より優れたデータ統合機能を取り入れるように進化し、患者と臨床試験のより迅速かつ正確なマッチングを可能にしました。米国のFDAなどの規制機関は、COVID-19関連の臨床試験に対して迅速な審査プロセスを導入しました。

しかし、開発業務受託機関（CRO）は有能な人材の確保と維持に苦慮しています。CROは、製薬会社、バイオテクノロジー企業、医療機器メーカー、学術研究機関などと、熟練した科学者の獲得にしのぎを削っています。効果的に競争するためには、これらの企業は給与や福利厚生を増やさなければならないです。しかし、これは特に小規模の臨床試験サービスプロバイダーにとっては、財務や成果に悪影響を及ぼす可能性があります。このような有能な専門家の不足は、新しい技術や手法の採用や今後数年間の市場の成長を阻害する可能性があります。今後数年間は、これらのサービスをCROにアウトソーシングする需要の高まりが市場拡大の原動力になると予想されるが、熟練労働者の不足が市場の成長を抑制する可能性があります。

展開モードの展望

導入形態別に見ると、市場はウェブ＆クラウドベースとオンプレミスに区分されます。オンプレミス型は、2022年のc市場でかなりの収益シェアを獲得しました。オンプレミス型とは、クラウドベースやウェブベースのソリューションとは異なり、医療機関や研究機関の物理的なインフラ内にソフトウェアをインストールして運用することを指します。オンプレミス・ソリューションでは、より広範なカスタマイズ・オプションが提供されることが多いです。臨床試験マッチングソフトウェアは、医療機関の特定の要件に合わせてカスタマイズできるため、医療機関のワークフローやニーズに完全に適合します。オンプレミス型は、管理、カスタマイズ、データセキュリティの面でメリットがあります。

最終用途の展望

最終用途に基づき、市場は製薬・バイオテクノロジー企業、CRO、医療機器企業に細分化されます。2022年には、製薬・バイオテクノロジー企業セグメントが市場で最も高い収益シェアを占めました。製薬・バイオテクノロジー企業は市場で重要な役割を果たしています。これらの企業は、新薬や治療法の研究、開発、試験に携わっており、研究に適した参加者を特定するために臨床試験マッチングソフトウェアに依存しています。臨床試験マッチング・ソフトウェアは、製薬企業やバイオテクノロジー企業にとって医薬品開発プロセスに不可欠な要素です。患者の募集からデータ分析に至るまで、臨床試験のさまざまな側面の合理化を支援し、最終的に新薬や治療法の開発と承認の成功に貢献しています。

地域別展望

地域別では、北米、欧州、アジア太平洋、LAMEAで市場を分析しています。2022年には、北米地域が市場で最も高い収益シェアを記録しました。米国では製薬会社やバイオテクノロジー企業による臨床試験マッチングソフトウェアの採用が増加しているためです。また、同地域には強固で確立された製薬業界があり、多くの企業が臨床試験マッチングソフトウェアの作成に投資しており、市場拡大を後押ししています。さらに、臨床試験マッチング・ソフトウェアを開発・導入することで、規制環境も恩恵を受ける。ITおよびAIベースのソリューションに関する多様な取り組みと、臨床試験マッチングおよび患者マッチングソフトウェアの採用拡大が、この地域の市場拡大に寄与しています。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場の概要

• 主なハイライト

第3章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因
• ポーターのファイブフォース分析

第4章 世界の臨床試験マッチングソフトウェア市場：展開モード別

• 世界のウェブおよびクラウドベース市場：地域別
• 世界のオンプレミス市場：地域別

第5章 世界の市場：、最終用途別

• 世界の製薬およびバイオテクノロジー企業市場：地域別
• 世界のCRO市場：地域別
• 世界の医療機器企業市場：地域別

第6章 世界の市場：、地域別

• 北米の市場
  • 北米の市場：展開モード別
    • 北米の国別ウェブおよびクラウドベース市場
    • 北米の国別オンプレミス市場
  • 北米の市場：最終用途別
    • 北米の製薬およびバイオテクノロジー企業の国別市場
    • 北米の国別CRO市場
    • 北米の医療機器企業市場：（国別）
  • 北米の市場：国別
    • 米国の臨床試験マッチングソフトウェア市場
    • カナダの臨床試験マッチングソフトウェア市場
    • メキシコの臨床試験マッチングソフトウェア市場
    • 残りの北米の市場
• 欧州の市場
  • 欧州の市場：展開モード別
    • 欧州の国別ウェブおよびクラウドベース市場
    • 欧州の国別オンプレミス市場
  • 欧州の市場：最終用途別
    • 欧州の国別製薬・バイオテクノロジー企業市場
    • 国別の欧州CRO市場
    • 欧州の医療機器企業市場：（国別）
  • 欧州の市場：国別
    • ドイツの臨床試験マッチングソフトウェア市場
    • 英国の臨床試験マッチングソフトウェア市場
    • フランスの臨床試験マッチングソフトウェア市場
    • ロシアの臨床試験マッチングソフトウェア市場
    • スペインの臨床試験マッチングソフトウェア市場
    • イタリアの臨床試験マッチングソフトウェア市場
    • 残りの欧州の市場
• アジア太平洋の市場
  • アジア太平洋の市場：展開モード別
    • アジア太平洋地域の国別ウェブおよびクラウドベース市場
    • アジア太平洋地域の国別オンプレミス市場
  • アジア太平洋の市場：最終用途別
    • アジア太平洋地域の製薬・バイオテクノロジー企業市場：（国別）
    • アジア太平洋地域の国別CRO市場
    • アジア太平洋地域の医療機器企業市場：（国別）
  • アジア太平洋の市場：国別
    • 中国の臨床試験マッチングソフトウェア市場
    • 日本の臨床試験マッチングソフトウェア市場
    • インドの臨床試験マッチングソフトウェア市場
    • 韓国の臨床試験マッチングソフトウェア市場
    • シンガポールの臨床試験マッチングソフトウェア市場
    • マレーシアの臨床試験マッチングソフトウェア市場
    • 残りのアジア太平洋の市場
• ラテンアメリカ・中東・アフリカの市場
  • ラテンアメリカ・中東・アフリカの市場：展開モード別
    • LAMEAウェブおよびクラウドベースの国別市場
    • 国別のLAMEAオンプレミス市場
  • ラテンアメリカ・中東・アフリカの市場：最終用途別
    • 国別のLAMEA製薬およびバイオテクノロジー企業市場
    • 国別のLAMEA CRO市場
    • 国別のLAMEA医療機器企業市場
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジルの臨床試験マッチングソフトウェア市場
    • アルゼンチンの臨床試験マッチングソフトウェア市場
    • UAEの臨床試験マッチングソフトウェア市場
    • サウジアラビアの臨床試験マッチングソフトウェア市場
    • 南アフリカの臨床試験マッチングソフトウェア市場
    • ナイジェリアの臨床試験マッチングソフトウェア市場
    • 残りのラテンアメリカ・中東・アフリカの市場

第7章 企業プロファイル

• Clario
• IBM Corporation
• Antidote Technologies, Inc
• Ofni Systems Inc
• Advarra, Inc
• ArisGlobal LLC（Nordic Capital Limited）
• Teckro, Inc
• BSI Business Systems Integration AG
• Clinical Trials Mobile Application
• Optimapharm do.o

第8章 臨床試験マッチングソフトウェア市場にとって勝利は必須

LIST OF TABLES

• TABLE 1 Global Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 2 Global Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 3 Global Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 4 Global Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 5 Global Web & Cloud-based Market, by Region, 2019 - 2022, USD Thousands
• TABLE 6 Global Web & Cloud-based Market, by Region, 2023 - 2030, USD Thousands
• TABLE 7 Global On-premise Market, by Region, 2019 - 2022, USD Thousands
• TABLE 8 Global On-premise Market, by Region, 2023 - 2030, USD Thousands
• TABLE 9 Global Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 10 Global Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 11 Global Pharmaceutical & Biotechnology Companies Market, by Region, 2019 - 2022, USD Thousands
• TABLE 12 Global Pharmaceutical & Biotechnology Companies Market, by Region, 2023 - 2030, USD Thousands
• TABLE 13 Global CROs Market, by Region, 2019 - 2022, USD Thousands
• TABLE 14 Global CROs Market, by Region, 2023 - 2030, USD Thousands
• TABLE 15 Global Medical Device Firms Market, by Region, 2019 - 2022, USD Thousands
• TABLE 16 Global Medical Device Firms Market, by Region, 2023 - 2030, USD Thousands
• TABLE 17 Global Clinical Trials Matching Software Market, by Region, 2019 - 2022, USD Thousands
• TABLE 18 Global Clinical Trials Matching Software Market, by Region, 2023 - 2030, USD Thousands
• TABLE 19 North America Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 20 North America Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 21 North America Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 22 North America Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 23 North America Web & Cloud-based Market, by Country, 2019 - 2022, USD Thousands
• TABLE 24 North America Web & Cloud-based Market, by Country, 2023 - 2030, USD Thousands
• TABLE 25 North America On-premise Market, by Country, 2019 - 2022, USD Thousands
• TABLE 26 North America On-premise Market, by Country, 2023 - 2030, USD Thousands
• TABLE 27 North America Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 28 North America Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 29 North America Pharmaceutical & Biotechnology Companies Market, by Country, 2019 - 2022, USD Thousands
• TABLE 30 North America Pharmaceutical & Biotechnology Companies Market, by Country, 2023 - 2030, USD Thousands
• TABLE 31 North America CROs Market, by Country, 2019 - 2022, USD Thousands
• TABLE 32 North America CROs Market, by Country, 2023 - 2030, USD Thousands
• TABLE 33 North America Medical Device Firms Market, by Country, 2019 - 2022, USD Thousands
• TABLE 34 North America Medical Device Firms Market, by Country, 2023 - 2030, USD Thousands
• TABLE 35 North America Clinical Trials Matching Software Market, by Country, 2019 - 2022, USD Thousands
• TABLE 36 North America Clinical Trials Matching Software Market, by Country, 2023 - 2030, USD Thousands
• TABLE 37 US Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 38 US Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 39 US Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 40 US Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 41 US Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 42 US Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 43 Canada Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 44 Canada Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 45 Canada Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 46 Canada Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 47 Canada Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 48 Canada Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 49 Mexico Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 50 Mexico Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 51 Mexico Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 52 Mexico Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 53 Mexico Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 54 Mexico Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 55 Rest of North America Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 56 Rest of North America Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 57 Rest of North America Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 58 Rest of North America Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 59 Rest of North America Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 60 Rest of North America Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 61 Europe Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 62 Europe Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 63 Europe Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 64 Europe Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 65 Europe Web & Cloud-based Market, by Country, 2019 - 2022, USD Thousands
• TABLE 66 Europe Web & Cloud-based Market, by Country, 2023 - 2030, USD Thousands
• TABLE 67 Europe On-premise Market, by Country, 2019 - 2022, USD Thousands
• TABLE 68 Europe On-premise Market, by Country, 2023 - 2030, USD Thousands
• TABLE 69 Europe Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 70 Europe Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 71 Europe Pharmaceutical & Biotechnology Companies Market, by Country, 2019 - 2022, USD Thousands
• TABLE 72 Europe Pharmaceutical & Biotechnology Companies Market, by Country, 2023 - 2030, USD Thousands
• TABLE 73 Europe CROs Market, by Country, 2019 - 2022, USD Thousands
• TABLE 74 Europe CROs Market, by Country, 2023 - 2030, USD Thousands
• TABLE 75 Europe Medical Device Firms Market, by Country, 2019 - 2022, USD Thousands
• TABLE 76 Europe Medical Device Firms Market, by Country, 2023 - 2030, USD Thousands
• TABLE 77 Europe Clinical Trials Matching Software Market, by Country, 2019 - 2022, USD Thousands
• TABLE 78 Europe Clinical Trials Matching Software Market, by Country, 2023 - 2030, USD Thousands
• TABLE 79 Germany Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 80 Germany Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 81 Germany Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 82 Germany Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 83 Germany Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 84 Germany Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 85 UK Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 86 UK Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 87 UK Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 88 UK Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 89 UK Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 90 UK Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 91 France Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 92 France Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 93 France Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 94 France Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 95 France Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 96 France Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 97 Russia Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 98 Russia Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 99 Russia Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 100 Russia Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 101 Russia Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 102 Russia Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 103 Spain Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 104 Spain Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 105 Spain Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 106 Spain Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 107 Spain Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 108 Spain Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 109 Italy Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 110 Italy Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 111 Italy Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 112 Italy Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 113 Italy Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 114 Italy Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 115 Rest of Europe Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 116 Rest of Europe Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 117 Rest of Europe Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 118 Rest of Europe Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 119 Rest of Europe Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 120 Rest of Europe Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 121 Asia Pacific Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 122 Asia Pacific Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 123 Asia Pacific Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 124 Asia Pacific Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 125 Asia Pacific Web & Cloud-based Market, by Country, 2019 - 2022, USD Thousands
• TABLE 126 Asia Pacific Web & Cloud-based Market, by Country, 2023 - 2030, USD Thousands
• TABLE 127 Asia Pacific On-premise Market, by Country, 2019 - 2022, USD Thousands
• TABLE 128 Asia Pacific On-premise Market, by Country, 2023 - 2030, USD Thousands
• TABLE 129 Asia Pacific Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 130 Asia Pacific Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 131 Asia Pacific Pharmaceutical & Biotechnology Companies Market, by Country, 2019 - 2022, USD Thousands
• TABLE 132 Asia Pacific Pharmaceutical & Biotechnology Companies Market, by Country, 2023 - 2030, USD Thousands
• TABLE 133 Asia Pacific CROs Market, by Country, 2019 - 2022, USD Thousands
• TABLE 134 Asia Pacific CROs Market, by Country, 2023 - 2030, USD Thousands
• TABLE 135 Asia Pacific Medical Device Firms Market, by Country, 2019 - 2022, USD Thousands
• TABLE 136 Asia Pacific Medical Device Firms Market, by Country, 2023 - 2030, USD Thousands
• TABLE 137 Asia Pacific Clinical Trials Matching Software Market, by Country, 2019 - 2022, USD Thousands
• TABLE 138 Asia Pacific Clinical Trials Matching Software Market, by Country, 2023 - 2030, USD Thousands
• TABLE 139 China Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 140 China Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 141 China Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 142 China Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 143 China Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 144 China Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 145 Japan Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 146 Japan Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 147 Japan Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 148 Japan Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 149 Japan Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 150 Japan Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 151 India Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 152 India Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 153 India Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 154 India Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 155 India Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 156 India Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 157 South Korea Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 158 South Korea Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 159 South Korea Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 160 South Korea Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 161 South Korea Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 162 South Korea Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 163 Singapore Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 164 Singapore Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 165 Singapore Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 166 Singapore Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 167 Singapore Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 168 Singapore Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 169 Malaysia Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 170 Malaysia Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 171 Malaysia Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 172 Malaysia Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 173 Malaysia Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 174 Malaysia Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 175 Rest of Asia Pacific Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 176 Rest of Asia Pacific Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 177 Rest of Asia Pacific Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 178 Rest of Asia Pacific Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 179 Rest of Asia Pacific Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 180 Rest of Asia Pacific Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 181 LAMEA Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 182 LAMEA Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 183 LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 184 LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 185 LAMEA Web & Cloud-based Market, by Country, 2019 - 2022, USD Thousands
• TABLE 186 LAMEA Web & Cloud-based Market, by Country, 2023 - 2030, USD Thousands
• TABLE 187 LAMEA On-premise Market, by Country, 2019 - 2022, USD Thousands
• TABLE 188 LAMEA On-premise Market, by Country, 2023 - 2030, USD Thousands
• TABLE 189 LAMEA Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 190 LAMEA Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 191 LAMEA Pharmaceutical & Biotechnology Companies Market, by Country, 2019 - 2022, USD Thousands
• TABLE 192 LAMEA Pharmaceutical & Biotechnology Companies Market, by Country, 2023 - 2030, USD Thousands
• TABLE 193 LAMEA CROs Market, by Country, 2019 - 2022, USD Thousands
• TABLE 194 LAMEA CROs Market, by Country, 2023 - 2030, USD Thousands
• TABLE 195 LAMEA Medical Device Firms Market, by Country, 2019 - 2022, USD Thousands
• TABLE 196 LAMEA Medical Device Firms Market, by Country, 2023 - 2030, USD Thousands
• TABLE 197 LAMEA Clinical Trials Matching Software Market, by Country, 2019 - 2022, USD Thousands
• TABLE 198 LAMEA Clinical Trials Matching Software Market, by Country, 2023 - 2030, USD Thousands
• TABLE 199 Brazil Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 200 Brazil Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 201 Brazil Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 202 Brazil Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 203 Brazil Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 204 Brazil Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 205 Argentina Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 206 Argentina Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 207 Argentina Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 208 Argentina Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 209 Argentina Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 210 Argentina Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 211 UAE Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 212 UAE Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 213 UAE Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 214 UAE Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 215 UAE Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 216 UAE Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 217 Saudi Arabia Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 218 Saudi Arabia Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 219 Saudi Arabia Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 220 Saudi Arabia Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 221 Saudi Arabia Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 222 Saudi Arabia Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 223 South Africa Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 224 South Africa Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 225 South Africa Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 226 South Africa Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 227 South Africa Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 228 South Africa Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 229 Nigeria Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 230 Nigeria Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 231 Nigeria Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 232 Nigeria Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 233 Nigeria Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 234 Nigeria Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 235 Rest of LAMEA Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
• TABLE 236 Rest of LAMEA Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
• TABLE 237 Rest of LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
• TABLE 238 Rest of LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
• TABLE 239 Rest of LAMEA Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
• TABLE 240 Rest of LAMEA Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
• TABLE 241 Key Information - Clario
• TABLE 242 Key Information - IBM Corporation
• TABLE 243 Key Information - Antidote Technologies, Inc.
• TABLE 244 Key Information - Ofni Systems Inc.
• TABLE 245 Key Information - Advarra, Inc.
• TABLE 246 Key Information - ArisGlobal LLC
• TABLE 247 Key Information - Teckro, Inc.
• TABLE 248 Key Information - BSI Business Systems Integration AG
• TABLE 249 Key Information - Clinical Trials Mobile Application
• TABLE 250 Key Information - Optimapharm d.o.o.

The Global Clinical Trials Matching Software Market size is expected to reach $362.7 million by 2030, rising at a market growth of 13.5% CAGR during the forecast period.

Recent trends indicate that leading pharmaceutical companies are increasing R&D savings by substantially investing in R&D for long-term returns and nurturing collaborative research endeavors. Hence, Pharmaceutical & Biotechnology Companies segment would acquire around 2/5th share in the market by 2030. Increasing R&D expenditures in the pharmaceutical and biopharmaceutical industries are driving a shift toward comprehensive integrated or functionally outsourced services covering the entire drug discovery and development process, from early to late-stage development. Some of the factors impacting the market are Increasing market competition in clinical trials matching software, technological advancements in the market, and shortage of skilled professionals.

Market competition plays a significant role in the growth and development of the market. Increased competition can positively affect this industry, driving innovation, improving product offerings, and expanding the market. Competition encourages software providers to innovate and develop new features, functionalities, and technologies. Companies strive to differentiate themselves by offering unique solutions that address the evolving needs of pharmaceutical companies, research institutions, and healthcare organizations. Additionally, Technological advancements in the market have significantly transformed how clinical trials are conducted and managed. These innovations have improved efficiency, data accuracy, patient engagement, and trial success rates. AI and machine learning algorithms analyze large datasets quickly, helping researchers identify suitable patient cohorts and predict patient responses to treatments. As technology evolves, the industry will likely see further innovations that enhance the conduct and management of clinical trials. These factors will expand market growth.

Moreover, The COVID-19 pandemic significantly impacted various aspects of the healthcare industry, including the market. The COVID-19 pandemic underscored the importance of clinical trials in drug development and public health. This increased awareness and urgency drove more significant demand for clinical trials matching software as researchers and pharmaceutical companies sought to accelerate trials related to COVID-19 treatments and vaccines. The pandemic emphasized the need for more efficient data sharing and analysis in the healthcare and clinical trials sectors. Clinical trials matching software evolved to incorporate better data integration capabilities, enabling faster and more accurate matching of patients with trials. Regulatory agencies, such as the FDA in the United States, implemented expedited review processes for COVID-19-related clinical trials.

However, Contract research organizations (CROs) struggle to locate and retain qualified personnel. They compete with pharmaceutical companies, biotechnology companies, medical device manufacturers, and academic research institutions for skilled and seasoned scientists. To effectively compete, these businesses must increase pay and benefits. However, this can have a negative effect on their finances and outcomes, particularly for small-scale clinical trial service providers. This shortage of qualified professionals may impede the adoption of new technologies and methodologies and the market's growth over the next few years. In the coming years, the rising demand for outsourcing these services to CROs is anticipated to drive market expansion, but the lack of skilled workers can restrain market growth.

Deployment Mode Outlook

On the basis of Deployment Mode, the market is segmented into web & cloud based and on-premises. The on-premises segment acquired a substantial revenue share in the c market in 2022. On-premises-based deployment in the market refers to the installation and operation of the software within the physical infrastructure of a healthcare organization or research institution, as opposed to utilizing cloud-based or web-based solutions. On-premises solutions often provide more extensive customization options. Clinical trials matching software can be tailored to meet specific institutional requirements, ensuring it aligns perfectly with the organization's workflow and needs. On-premises deployment in the market provides organizations with benefits for control, customization, and data security.

End-use Outlook

Based on end-use, the market is fragmented into pharmaceutical & biotechnology companies, CROs, and medical device firms. In 2022, the pharmaceutical and biotechnology companies segment held the highest revenue share in the market. Pharmaceutical and biotechnology companies play a significant role in the market. These companies are involved in the research, development, and testing of new drugs and therapies, and they rely on clinical trials matching software to identify suitable participants for their studies. Clinical trials matching software is an integral part of the drug development process for pharmaceutical and biotechnology companies. It helps streamline various aspects of clinical trials, from patient recruitment to data analysis, ultimately contributing to the successful development and approval of new drugs and therapies.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. Due to the rise in clinical trials matching software adoption by pharmaceutical and biotechnology firms in the U.S. In addition, the region has a robust and well-established pharmaceutical industry, and numerous companies are investing in creating clinical trial matching software, propelling market expansion. In addition, the regulatory environment benefits from developing and implementing clinical trial matching software. Diverse initiatives relating to IT and AI-based solutions and the increased adoption of clinical trials matching and patient-matching software contribute to expanding the regional market.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Clario, IBM Corporation, Antidote Technologies, Inc., Ofni Systems Inc., Advarra, Inc., ArisGlobal LLC (Nordic Capital Limited), Teckro, Inc., BSI Business Systems Integration AG, Clinical Trials Mobile Application, Optimapharm d.o.o.

Scope of the Study

Market Segments covered in the Report:

By Deployment Mode

• Web & Cloud-based
• On-premises

By End-use

• Pharmaceutical & Biotechnology Companies
• CROs
• Medical Device Firms

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Clario
• IBM Corporation
• Antidote Technologies, Inc.
• Ofni Systems Inc.
• Advarra, Inc.
• ArisGlobal LLC (Nordic Capital Limited)
• Teckro, Inc.
• BSI Business Systems Integration AG
• Clinical Trials Mobile Application
• Optimapharm d.o.o.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Clinical Trials Matching Software Market, by Deployment Mode
  • 1.4.2 Global Clinical Trials Matching Software Market, by End-use
  • 1.4.3 Global Clinical Trials Matching Software Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.1 Porter's Five Force Analysis

Chapter 4. Global Clinical Trials Matching Software Market, by Deployment Mode

• 4.1 Global Web & Cloud-based Market, by Region
• 4.2 Global On-premise Market, by Region

Chapter 5. Global Clinical Trials Matching Software Market, by End-use

• 5.1 Global Pharmaceutical & Biotechnology Companies Market, by Region
• 5.2 Global CROs Market, by Region
• 5.3 Global Medical Device Firms Market, by Region

Chapter 6. Global Clinical Trials Matching Software Market, by Region

• 6.1 North America Clinical Trials Matching Software Market
  • 6.1.1 North America Clinical Trials Matching Software Market, by Deployment Mode
    • 6.1.1.1 North America Web & Cloud-based Market, by Country
    • 6.1.1.2 North America On-premise Market, by Country
  • 6.1.2 North America Clinical Trials Matching Software Market, by End-use
    • 6.1.2.1 North America Pharmaceutical & Biotechnology Companies Market, by Country
    • 6.1.2.2 North America CROs Market, by Country
    • 6.1.2.3 North America Medical Device Firms Market, by Country
  • 6.1.3 North America Clinical Trials Matching Software Market, by Country
    • 6.1.3.1 US Clinical Trials Matching Software Market
      • 6.1.3.1.1 US Clinical Trials Matching Software Market, by Deployment Mode
      • 6.1.3.1.2 US Clinical Trials Matching Software Market, by End-use
    • 6.1.3.2 Canada Clinical Trials Matching Software Market
      • 6.1.3.2.1 Canada Clinical Trials Matching Software Market, by Deployment Mode
      • 6.1.3.2.2 Canada Clinical Trials Matching Software Market, by End-use
    • 6.1.3.3 Mexico Clinical Trials Matching Software Market
      • 6.1.3.3.1 Mexico Clinical Trials Matching Software Market, by Deployment Mode
      • 6.1.3.3.2 Mexico Clinical Trials Matching Software Market, by End-use
    • 6.1.3.4 Rest of North America Clinical Trials Matching Software Market
      • 6.1.3.4.1 Rest of North America Clinical Trials Matching Software Market, by Deployment Mode
      • 6.1.3.4.2 Rest of North America Clinical Trials Matching Software Market, by End-use
• 6.2 Europe Clinical Trials Matching Software Market
  • 6.2.1 Europe Clinical Trials Matching Software Market, by Deployment Mode
    • 6.2.1.1 Europe Web & Cloud-based Market, by Country
    • 6.2.1.2 Europe On-premise Market, by Country
  • 6.2.2 Europe Clinical Trials Matching Software Market, by End-use
    • 6.2.2.1 Europe Pharmaceutical & Biotechnology Companies Market, by Country
    • 6.2.2.2 Europe CROs Market, by Country
    • 6.2.2.3 Europe Medical Device Firms Market, by Country
  • 6.2.3 Europe Clinical Trials Matching Software Market, by Country
    • 6.2.3.1 Germany Clinical Trials Matching Software Market
      • 6.2.3.1.1 Germany Clinical Trials Matching Software Market, by Deployment Mode
      • 6.2.3.1.2 Germany Clinical Trials Matching Software Market, by End-use
    • 6.2.3.2 UK Clinical Trials Matching Software Market
      • 6.2.3.2.1 UK Clinical Trials Matching Software Market, by Deployment Mode
      • 6.2.3.2.2 UK Clinical Trials Matching Software Market, by End-use
    • 6.2.3.3 France Clinical Trials Matching Software Market
      • 6.2.3.3.1 France Clinical Trials Matching Software Market, by Deployment Mode
      • 6.2.3.3.2 France Clinical Trials Matching Software Market, by End-use
    • 6.2.3.4 Russia Clinical Trials Matching Software Market
      • 6.2.3.4.1 Russia Clinical Trials Matching Software Market, by Deployment Mode
      • 6.2.3.4.2 Russia Clinical Trials Matching Software Market, by End-use
    • 6.2.3.5 Spain Clinical Trials Matching Software Market
      • 6.2.3.5.1 Spain Clinical Trials Matching Software Market, by Deployment Mode
      • 6.2.3.5.2 Spain Clinical Trials Matching Software Market, by End-use
    • 6.2.3.6 Italy Clinical Trials Matching Software Market
      • 6.2.3.6.1 Italy Clinical Trials Matching Software Market, by Deployment Mode
      • 6.2.3.6.2 Italy Clinical Trials Matching Software Market, by End-use
    • 6.2.3.7 Rest of Europe Clinical Trials Matching Software Market
      • 6.2.3.7.1 Rest of Europe Clinical Trials Matching Software Market, by Deployment Mode
      • 6.2.3.7.2 Rest of Europe Clinical Trials Matching Software Market, by End-use
• 6.3 Asia Pacific Clinical Trials Matching Software Market
  • 6.3.1 Asia Pacific Clinical Trials Matching Software Market, by Deployment Mode
    • 6.3.1.1 Asia Pacific Web & Cloud-based Market, by Country
    • 6.3.1.2 Asia Pacific On-premise Market, by Country
  • 6.3.2 Asia Pacific Clinical Trials Matching Software Market, by End-use
    • 6.3.2.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market, by Country
    • 6.3.2.2 Asia Pacific CROs Market, by Country
    • 6.3.2.3 Asia Pacific Medical Device Firms Market, by Country
  • 6.3.3 Asia Pacific Clinical Trials Matching Software Market, by Country
    • 6.3.3.1 China Clinical Trials Matching Software Market
      • 6.3.3.1.1 China Clinical Trials Matching Software Market, by Deployment Mode
      • 6.3.3.1.2 China Clinical Trials Matching Software Market, by End-use
    • 6.3.3.2 Japan Clinical Trials Matching Software Market
      • 6.3.3.2.1 Japan Clinical Trials Matching Software Market, by Deployment Mode
      • 6.3.3.2.2 Japan Clinical Trials Matching Software Market, by End-use
    • 6.3.3.3 India Clinical Trials Matching Software Market
      • 6.3.3.3.1 India Clinical Trials Matching Software Market, by Deployment Mode
      • 6.3.3.3.2 India Clinical Trials Matching Software Market, by End-use
    • 6.3.3.4 South Korea Clinical Trials Matching Software Market
      • 6.3.3.4.1 South Korea Clinical Trials Matching Software Market, by Deployment Mode
      • 6.3.3.4.2 South Korea Clinical Trials Matching Software Market, by End-use
    • 6.3.3.5 Singapore Clinical Trials Matching Software Market
      • 6.3.3.5.1 Singapore Clinical Trials Matching Software Market, by Deployment Mode
      • 6.3.3.5.2 Singapore Clinical Trials Matching Software Market, by End-use
    • 6.3.3.6 Malaysia Clinical Trials Matching Software Market
      • 6.3.3.6.1 Malaysia Clinical Trials Matching Software Market, by Deployment Mode
      • 6.3.3.6.2 Malaysia Clinical Trials Matching Software Market, by End-use
    • 6.3.3.7 Rest of Asia Pacific Clinical Trials Matching Software Market
      • 6.3.3.7.1 Rest of Asia Pacific Clinical Trials Matching Software Market, by Deployment Mode
      • 6.3.3.7.2 Rest of Asia Pacific Clinical Trials Matching Software Market, by End-use
• 6.4 LAMEA Clinical Trials Matching Software Market
  • 6.4.1 LAMEA Clinical Trials Matching Software Market, by Deployment Mode
    • 6.4.1.1 LAMEA Web & Cloud-based Market, by Country
    • 6.4.1.2 LAMEA On-premise Market, by Country
  • 6.4.2 LAMEA Clinical Trials Matching Software Market, by End-use
    • 6.4.2.1 LAMEA Pharmaceutical & Biotechnology Companies Market, by Country
    • 6.4.2.2 LAMEA CROs Market, by Country
    • 6.4.2.3 LAMEA Medical Device Firms Market, by Country
  • 6.4.3 LAMEA Clinical Trials Matching Software Market, by Country
    • 6.4.3.1 Brazil Clinical Trials Matching Software Market
      • 6.4.3.1.1 Brazil Clinical Trials Matching Software Market, by Deployment Mode
      • 6.4.3.1.2 Brazil Clinical Trials Matching Software Market, by End-use
    • 6.4.3.2 Argentina Clinical Trials Matching Software Market
      • 6.4.3.2.1 Argentina Clinical Trials Matching Software Market, by Deployment Mode
      • 6.4.3.2.2 Argentina Clinical Trials Matching Software Market, by End-use
    • 6.4.3.3 UAE Clinical Trials Matching Software Market
      • 6.4.3.3.1 UAE Clinical Trials Matching Software Market, by Deployment Mode
      • 6.4.3.3.2 UAE Clinical Trials Matching Software Market, by End-use
    • 6.4.3.4 Saudi Arabia Clinical Trials Matching Software Market
      • 6.4.3.4.1 Saudi Arabia Clinical Trials Matching Software Market, by Deployment Mode
      • 6.4.3.4.2 Saudi Arabia Clinical Trials Matching Software Market, by End-use
    • 6.4.3.5 South Africa Clinical Trials Matching Software Market
      • 6.4.3.5.1 South Africa Clinical Trials Matching Software Market, by Deployment Mode
      • 6.4.3.5.2 South Africa Clinical Trials Matching Software Market, by End-use
    • 6.4.3.6 Nigeria Clinical Trials Matching Software Market
      • 6.4.3.6.1 Nigeria Clinical Trials Matching Software Market, by Deployment Mode
      • 6.4.3.6.2 Nigeria Clinical Trials Matching Software Market, by End-use
    • 6.4.3.7 Rest of LAMEA Clinical Trials Matching Software Market
      • 6.4.3.7.1 Rest of LAMEA Clinical Trials Matching Software Market, by Deployment Mode
      • 6.4.3.7.2 Rest of LAMEA Clinical Trials Matching Software Market, by End-use

Chapter 7. Company Profiles

• 7.1 Clario
  • 7.1.1 Company Overview
  • 7.1.2 Recent strategies and developments:
    • 7.1.2.1 Partnerships, Collaborations, and Agreements:
  • 7.1.3 SWOT Analysis
• 7.2 IBM Corporation
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental and Regional Analysis
  • 7.2.4 Research & Development Expenses
  • 7.2.5 SWOT Analysis
• 7.3 Antidote Technologies, Inc.
  • 7.3.1 Company Overview
  • 7.3.2 Recent strategies and developments:
    • 7.3.2.1 Partnerships, Collaborations, and Agreements:
  • 7.3.3 SWOT Analysis
• 7.4 Ofni Systems Inc.
  • 7.4.1 Company Overview
  • 7.4.2 SWOT Analysis
• 7.5 Advarra, Inc.
  • 7.5.1 Company Overview
  • 7.5.2 SWOT Analysis
• 7.6 ArisGlobal LLC (Nordic Capital Limited)
  • 7.6.1 Company Overview
  • 7.6.2 Recent strategies and developments:
    • 7.6.2.1 Geographical Expansions:
  • 7.6.3 SWOT Analysis
• 7.7 Teckro, Inc.
  • 7.7.1 Company Overview
  • 7.7.2 SWOT Analysis
• 7.8 BSI Business Systems Integration AG
  • 7.8.1 Company Overview
  • 7.8.2 SWOT Analysis
• 7.9 Clinical Trials Mobile Application
  • 7.9.1 Company Overview
  • 7.9.2 SWOT Analysis
• 7.10. Optimapharm d.o.o.
  • 7.10.1 Company Overview
  • 7.10.2 SWOT Analysis

Chapter 8. Winning Imperative for Clinical Trials Matching Software Market